A recombinant vector derived from the host range-restricted and highly attenuated MVA strain of vaccinia virus stimulates protective immunity in mice to influenza virus
- 1 January 1994
- journal article
- research article
- Published by Elsevier BV in Vaccine
- Vol. 12 (11), 1032-1040
- https://doi.org/10.1016/0264-410x(94)90341-7
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Murine model for evaluation of protective immunity to influenza virusVaccine, 1993
- Immunisation with canarypox virus expressing rabies glycoproteinThe Lancet, 1992
- Influenza immunization: intranasal live vaccinia recombinant contrasted with parenteral inactivated vaccineVaccine, 1991
- Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickensVaccine, 1991
- Mapping of deletions in the genome of the highly attenuated vaccinia virus MVA and their influence on virulenceJournal of General Virology, 1991
- A dominant selectable marker for the construction of recombinant poxvirusesGene, 1988
- The Roles of Influenza Virus Haemagglutinin and Nueleoprotein in Protection: Analysis Using Vaccinia Virus RecombinantsScandinavian Journal of Immunology, 1987
- Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cellsNature, 1984
- Studies on poxvirus infections in irradiated animalsArchiv für die gesamte Virusforschung, 1980
- MVA-Stufenimpfung gegen PockenDeutsche Medizinische Wochenschrift (1946), 1974